CN102911281B - 从海藻提取物中纯化岩藻依聚糖的工艺方法 - Google Patents

从海藻提取物中纯化岩藻依聚糖的工艺方法 Download PDF

Info

Publication number
CN102911281B
CN102911281B CN201210417761.8A CN201210417761A CN102911281B CN 102911281 B CN102911281 B CN 102911281B CN 201210417761 A CN201210417761 A CN 201210417761A CN 102911281 B CN102911281 B CN 102911281B
Authority
CN
China
Prior art keywords
fucoidan
factor
pharmaceutical composition
purifying
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201210417761.8A
Other languages
English (en)
Chinese (zh)
Other versions
CN102911281A (zh
Inventor
帕特里克·N·嘉康利
詹尼弗·巴哈-戴维森
斯里尼瓦莎·普拉萨德
科克·约翰逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of CN102911281A publication Critical patent/CN102911281A/zh
Application granted granted Critical
Publication of CN102911281B publication Critical patent/CN102911281B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0036—Galactans; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201210417761.8A 2007-02-23 2008-02-01 从海藻提取物中纯化岩藻依聚糖的工艺方法 Active CN102911281B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89128707P 2007-02-23 2007-02-23
US60/891,287 2007-02-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2008800079552A Division CN101663326B (zh) 2007-02-23 2008-02-01 从海藻提取物中纯化岩藻依聚糖的工艺方法

Publications (2)

Publication Number Publication Date
CN102911281A CN102911281A (zh) 2013-02-06
CN102911281B true CN102911281B (zh) 2015-04-15

Family

ID=39545010

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2008800079552A Active CN101663326B (zh) 2007-02-23 2008-02-01 从海藻提取物中纯化岩藻依聚糖的工艺方法
CN201210417761.8A Active CN102911281B (zh) 2007-02-23 2008-02-01 从海藻提取物中纯化岩藻依聚糖的工艺方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN2008800079552A Active CN101663326B (zh) 2007-02-23 2008-02-01 从海藻提取物中纯化岩藻依聚糖的工艺方法

Country Status (7)

Country Link
US (2) US8748595B2 (enExample)
EP (3) EP2532686B1 (enExample)
JP (1) JP5679663B2 (enExample)
KR (1) KR101486931B1 (enExample)
CN (2) CN101663326B (enExample)
ES (2) ES2476250T3 (enExample)
WO (1) WO2008103234A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101486931B1 (ko) * 2007-02-23 2015-01-27 박스터 인터내쇼날 인코포레이티드 해조류 추출물로부터 푸코이단을 정제하는 방법
SI2379096T1 (sl) 2008-12-19 2020-03-31 Baxalta GmbH Zaviralci TFPI in postopki uporabe
JO3676B1 (ar) * 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
CN101659709B (zh) * 2009-09-18 2011-09-07 集美大学 岩藻聚糖的制备方法
AU2011205271B2 (en) * 2010-01-14 2014-01-30 Baxalta GmbH Methods and compositions for treating bleeding disorders
CA2793465C (en) 2010-03-19 2022-06-14 Baxter International Inc. Tfpi inhibitors and methods of use
US20130071426A1 (en) * 2010-05-27 2013-03-21 Laboratorios Leti, S.L. Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that transcur through a deficit of maturation of the cornified envelope
JP2013531012A (ja) * 2010-06-28 2013-08-01 ステムテック インターナショナル， インコーポレイテッド 幹細胞の移動を増強するための方法および組成物
WO2012071253A1 (en) * 2010-11-23 2012-05-31 Fmc Corporation Process for isolating fucoidan and laminarin from live, harvested seaweed
CN103338780A (zh) * 2010-12-20 2013-10-02 韩国食品研究院 含有腔昆布提取物和黑昆布提取物的用于正向变构调节gabaa-苯二氮杂*受体的组合物和用于产生镇静催眠效果的组合物
CN102321052B (zh) * 2011-05-26 2013-08-21 天津市尖峰天然产物研究开发有限公司 综合利用海带提取纯化岩藻黄质和岩藻聚糖硫酸酯的方法
US8846620B2 (en) 2011-07-19 2014-09-30 Baxter International Inc. Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
US20140186456A1 (en) * 2011-08-25 2014-07-03 Lillian M. Day Tripartite Bioactive Composition Providing Anti-Oxidant and Anti-Inflammatory Effects with Immune System and Stem Cell Production Enhancement
CN102417549B (zh) * 2011-11-07 2013-07-24 沈阳科思高科技有限公司 一种基于微波化学的褐藻活性多糖的提取方法
WO2013074801A1 (en) 2011-11-18 2013-05-23 Stemtech International, Inc. Use of foti to enhance stem cell mobilization and proliferation
NZ724133A (en) 2012-03-21 2020-07-31 Baxalta Inc Tfpi inhibitors and methods of use
ES2737025T3 (es) 2012-08-14 2020-01-09 Baxalta GmbH Métodos y sistemas para el cribado de composiciones que comprenden polisacáridos sulfados no anticoagulantes
WO2014113836A1 (en) * 2013-01-25 2014-07-31 Marinova Pty Ltd Treatment methods
CN104698159B (zh) * 2015-03-10 2017-03-08 中国科学院苏州生物医学工程技术研究所 一种内毒素含量的检测方法
US11957867B2 (en) * 2016-06-27 2024-04-16 Takeda Pharmaceutical Company Limited Syringe stabilizer
KR101721998B1 (ko) * 2016-08-16 2017-03-31 (주)한국바이오엔지니어링 이미, 이취, 및 염분 제거를 위한 반용매 정제기술이 적용된 후코이단 제조 방법
KR101866906B1 (ko) * 2017-04-05 2018-06-12 한남대학교 산학협력단 후코이단의 추출방법
CN108641008B (zh) * 2018-05-11 2020-07-24 大连工业大学 裙带菜孢子叶提取岩藻聚糖硫酸酯及脱除重金属的方法
AU2019311591B2 (en) * 2018-07-27 2021-11-04 Arc Medical Devices Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
US12186334B2 (en) 2018-07-27 2025-01-07 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
CN109134680B (zh) * 2018-09-10 2021-03-09 深圳华创生物医药科技有限公司 一种褐藻糖胶的提取和纯化方法及其应用
GB2579600B (en) 2018-12-05 2023-07-05 Byotrol Plc Anti-viral composition
CN112512667B (zh) 2019-03-05 2022-12-06 Arc医疗器械股份有限公司 用于粘性组合物的切向流过滤的系统和方法
RU2717672C1 (ru) * 2019-04-05 2020-03-25 Гордейчук Владимир Евгеньевич Способ стимуляции клеток иммунной системы человека
SE1950885A1 (en) 2019-07-11 2021-01-12 Faelker Knut Treatment of patients undergoing antiplatelet medication experiencing acute bleeding complications during / after surgery
KR102309085B1 (ko) 2019-12-13 2021-10-08 한국프라임제약주식회사 비소가 저감된 해조류 추출물 및 이의 제조방법
EP3932411A1 (en) * 2020-06-30 2022-01-05 GSK Consumer Healthcare SARL Antiviral pharmaceutical composition
CN112062871B (zh) * 2020-10-14 2022-06-28 福州海王福药制药有限公司 一种红藻多糖的制备方法
JP7770121B2 (ja) * 2021-06-30 2025-11-14 ポーラ化成工業株式会社 ヒアルロン酸受容体発現促進剤、これを含む皮膚外用剤並びに高分子ヒアルロン酸の保持効率向上方法
JP2025509154A (ja) 2022-03-08 2025-04-11 エクアシールド メディカル リミテッド ロボット医薬品調製システムにおける流体移送ステーション
CN115386013B (zh) * 2022-04-19 2023-05-12 广西中医药大学 一种具有强效抗凝活性的海带多糖及其制备方法和应用
CA3268254A1 (en) 2022-09-21 2024-03-28 Bioatlantis Limited PhlorOTANINS AND ALPHA-FUCANES TO TREAT TYPE 2 DIABETES
EP4389251A1 (en) 2022-12-23 2024-06-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Means and methods to purify and/or quantify fucoidan

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1328062A (zh) * 2001-04-28 2001-12-26 武汉大学 高纯度魔芋葡甘聚糖的提取工艺
CN1344565A (zh) * 2001-10-19 2002-04-17 汤洁 岩藻多糖酯作为抗病毒及免疫调节剂及其制备方法
US6593311B2 (en) * 1996-01-26 2003-07-15 Takara Shuzo Co., Ltd. Apoptosis inducers
CN1515592A (zh) * 2003-01-02 2004-07-28 合肥学院 微生物酶法制备低分子量岩藻多糖工艺

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064378B1 (en) * 1981-04-27 1987-02-11 The Public Health Laboratory Service Board Affinity chromatography using metal ions
JPS6157520A (ja) * 1984-08-29 1986-03-24 Kibun Food Chemiphar:Kk フコイダン純度の高い溶液又は、フコイダンの製造方法
JP3714426B2 (ja) 1994-02-01 2005-11-09 株式会社糖鎖工学研究所 フコイダンオリゴ糖組成物含有癌転移抑制剤
JP3371124B2 (ja) * 1996-12-24 2003-01-27 正邦 田幸 養殖オキナワモズクを原料とするアセチルフコイダンおよ びそれの製造法
JPH10195106A (ja) * 1997-01-13 1998-07-28 Masakuni Tako 養殖イトモズクからの純度の高いフコイダンの製造法
JP4347950B2 (ja) * 1999-06-14 2009-10-21 株式会社ヤクルト本社 高純度フコイダンおよびその製造方法
US20030039670A1 (en) * 1999-11-30 2003-02-27 Shigetoshi Mizutani Cosmetics
EP1327448A4 (en) * 2000-09-13 2005-06-15 Takara Bio Inc AGENTS MAINTAINING HOMEOSTASE
JP3676682B2 (ja) * 2001-01-26 2005-07-27 株式会社スペース商事 フコイダン含有抽出物の簡易な製造方法
JP4768142B2 (ja) * 2001-03-08 2011-09-07 協同乳業株式会社 フコイダンの簡易製造方法
JP2003155244A (ja) * 2002-09-13 2003-05-27 Kyodo Milk Industry Co Ltd モズク由来のフコイダンを含む食品
RU2347574C2 (ru) 2004-05-27 2009-02-27 Эвиджен, Инк. Способы лечения коагулопатий с использованием сульфатированных полисахаридов
BRPI0513382A (pt) * 2004-07-14 2008-05-06 Wyeth Corp composições e processos de purificação de glicoproteìna associada à mielina (mag)
KR101486931B1 (ko) * 2007-02-23 2015-01-27 박스터 인터내쇼날 인코포레이티드 해조류 추출물로부터 푸코이단을 정제하는 방법

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593311B2 (en) * 1996-01-26 2003-07-15 Takara Shuzo Co., Ltd. Apoptosis inducers
CN1328062A (zh) * 2001-04-28 2001-12-26 武汉大学 高纯度魔芋葡甘聚糖的提取工艺
CN1344565A (zh) * 2001-10-19 2002-04-17 汤洁 岩藻多糖酯作为抗病毒及免疫调节剂及其制备方法
CN1515592A (zh) * 2003-01-02 2004-07-28 合肥学院 微生物酶法制备低分子量岩藻多糖工艺

Also Published As

Publication number Publication date
CN102911281A (zh) 2013-02-06
US20100144667A1 (en) 2010-06-10
JP2010519383A (ja) 2010-06-03
EP3409694A1 (en) 2018-12-05
WO2008103234A1 (en) 2008-08-28
US9234051B2 (en) 2016-01-12
EP2121767B1 (en) 2014-04-09
US8748595B2 (en) 2014-06-10
US20140328827A1 (en) 2014-11-06
EP2532686A1 (en) 2012-12-12
CN101663326A (zh) 2010-03-03
EP2121767A1 (en) 2009-11-25
KR20090127142A (ko) 2009-12-09
KR101486931B1 (ko) 2015-01-27
CN101663326B (zh) 2013-03-20
EP2532686B1 (en) 2018-05-16
JP5679663B2 (ja) 2015-03-04
ES2683948T3 (es) 2018-09-28
HK1135120A1 (en) 2010-05-28
ES2476250T3 (es) 2014-07-14

Similar Documents

Publication Publication Date Title
CN102911281B (zh) 从海藻提取物中纯化岩藻依聚糖的工艺方法
Holmer et al. Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties
JP5232470B2 (ja) 硫酸化多糖を用いて出血性疾患を処置するための方法
US20090098185A1 (en) Method for treating thrombotic disorders using sulfated polysaccharides
CA2838793C (en) Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
Olson et al. Mechanism of action of heparin and heparin-like antithrombotics
HK1135120B (en) Process methods for fucoidan purification from seaweed extracts
HK40002622A (en) Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
Ventre FROM UNFRACTIONATED HEPARIN TO PENTASACCHARIDE: PARADIGM OF RIGOROUS SCIENCE GROWING IN THE UNDERSTANDING OF THE IN VIVO THROMBIN GENERATION
HK1142276B (en) Methods for treating bleeding disorders using sulfated polysaccharides

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20180213

Address after: Illinois

Co-patentee after: Hundred deep limited liability company

Patentee after: Hundred deep company

Address before: Illinois

Co-patentee before: Baxter Healthcare SA

Patentee before: Baxter International Inc.

TR01 Transfer of patent right
CP02 Change in the address of a patent holder

Address after: Illinois State

Co-patentee after: Hundred deep limited liability company

Patentee after: Hundred deep company

Address before: Illinois

Co-patentee before: Hundred deep limited liability company

Patentee before: Hundred deep company

CP02 Change in the address of a patent holder
TR01 Transfer of patent right

Effective date of registration: 20210705

Address after: Osaka

Patentee after: TAKEDA PHARMACEUTICAL Co.,Ltd.

Address before: Illinois, USA

Patentee before: Baishen Co.

Patentee before: BAXALTA GmbH

TR01 Transfer of patent right